Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 3Zollinger-Ellison Syndrome 2Stomach Neoplasms 2Gastroesophageal Reflux 2Barrett Esophagus 2Xerostomia 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Stomach Ulcer 1Pseudomyxoma Peritonei 1Oropharyngeal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia 1Mucositis 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, B-Cell 1Hemorrhage 1Helicobacter Infections 1Heartburn 1Head and Neck Neoplasms 1Gastritis, Atrophic 1Esophagitis, Peptic 1Endometrial Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoid Tumor 1Appendiceal Neoplasms 1

Interventions

Surveys and Questionnaires 3vandetanib 1pertuzumab 1gallium Ga 68 dotatate 1fluorodopa F 18 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Leflunomide 1Lansoprazole 1Immunotherapy 1Erlotinib Hydrochloride 1Drug Therapy 1Biological Therapy 1(18F)GTP1 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multiple Endocrine Neoplasia × Lansoprazole × Clear all
NCT00204373 2012-10-30

Treatment of Zollinger-Ellison Syndrome With Prevacid

University of Alabama at Birmingham

Phase 4 Completed
72 enrolled 8 charts
Endocrine

Multiple Endocrine Neoplasia, Zollinger-Ellison Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡